International Stem Cell (ISCO) Dividend Coverage Ratio (2012)
International Stem Cell's (ISCO) quarterly Dividend Coverage Ratio came in at 1.89 in Q4 2012, up 5.06% quarter-over-quarter from 1.8 in Q3 2012.
Powered by 
Analysis
International Stem Cell (ISCO) Dividend Coverage Ratio (2012) Analysis & Trends
International Stem Cell (ISCO) has reported Dividend Coverage Ratio for 1 consecutive years, with 1.89 the latest figure, recorded in Q4 2012.
- On a quarterly basis, Dividend Coverage Ratio changed N/A year-over-year to 1.89 in Q4 2012; TTM through Sep 2013 was 7.5, a N/A change from a year earlier, with the FY2010 full-year figure at 27.26, changed N/A from the prior year.
- Dividend Coverage Ratio was 1.89 for Q4 2012 at International Stem Cell, up from 1.8 in the prior quarter.
- Over five years, Dividend Coverage Ratio peaked at 1.89 in Q4 2012 and troughed at 2.37 in Q2 2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | - |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | - |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | - |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | - |
| 10 | International Stem Cell | 2.84 Mn | 1.75 Mn | 1.46 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2012 | 1.89 |
| Sep 30, 2012 | 1.80 |
| Jun 30, 2012 | -2.37 |